The clinical and financial impact of port-access coronary revascularization

D R Watson1, S B Duff

  • 1Riverside Methodist Hospitals, Columbus, OH, USA.

Insights

Port-access coronary bypass grafting (CABG) offers clinical benefits for select patients with coronary artery disease, including reduced ICU time and pain. However, this minimally invasive approach currently incurs higher institutional costs.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery

Background:

  • Coronary artery disease necessitates surgical intervention for many patients.
  • Traditional coronary artery bypass grafting (CABG) involves median sternotomy.
  • Advancements in surgical techniques aim to improve patient outcomes and recovery.

Purpose of the Study:

  • To evaluate the clinical and financial outcomes of port-access coronary bypass grafting (CABG).
  • To compare port-access CABG with standard median sternotomy CABG in terms of patient recovery and costs.

Main Methods:

  • A cohort of 100 patients underwent port-access CABG.
  • Clinical and financial data were compared to 531 patients who had standard median sternotomy CABG.
  • Key outcome measures included ICU stay, complications, pain, and hospital costs.

Main Results:

  • Port-access CABG showed no instances of aortic dissection, deep vein thrombosis, conversion to sternotomy, or death.
  • Patients undergoing port-access CABG experienced shorter ICU stays, less atrial fibrillation, reduced transfusion needs, and lower pain scores.
  • Despite similar lengths of stay, port-access CABG resulted in an average cost increase of $2703 per case.

Conclusions:

  • Port-access CABG is a safe and effective technique for selected patients with coronary artery disease, offering significant clinical advantages.
  • The current implementation of port-access CABG leads to increased institutional costs.
  • Further evaluation is needed to optimize the cost-effectiveness of this minimally invasive approach.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...